Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02436057 · ClinicalTrials.gov registry record · NA
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
A NA study of Constipation and Gastroesophageal Reflux, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 255
- Enrollment target
- 3
- Study locations
NCT02436057 is a NA study of Constipation and Gastroesophageal Reflux that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 255 participants, above the 201-participant average among 54 other Constipation trials with a reported enrollment target (27% higher). The trial reports 3 study locations across 2 states.
The verdict
NCT02436057, a NA study of Constipation and Gastroesophageal Reflux, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 255 participants
- Enrollment target
- 3
- Study locations
Study Summary
Through a four-year grant awarded to the University of California at Los Angeles in 2009, Dr. Brennan Spiegel served as a principal investigator (PI) for a project to develop and initially validate a bank of items to assess gastrointestinal (GI) symptoms for the National Institutes of Health's (NIH's) Patient Reported Outcomes Measurement Information System (PROMIS). By the end of the grant period in July 2013, the project team had successfully developed and initially validated eight scales measuring the most common GI symptoms. Afterwards, Dr. Spiegel's PROMIS team joined forces with the UCLA Computing Technology Research Laboratory (CTRL) and the University of Michigan Center for Healthcare Communication Research to develop the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) algorithm which is delivered via My GI Health, an open--source Internet based patient-provider portal (P3) designed to enhance the delivery of GI health care (www.MyGIHealth.org). Through My GI Health and AEGIS, patients are able to complete PROMIS GI symptom measures and provide additional information about their GI symptoms and histories from computers, tablets or smart phones without the constraints of physical locale. This information is condensed into a GI PROMIS scores report and initial GI history that patients' providers can review prior to or concurrent with seeing the patient. The report, which can be incorporated into the electronic health record (EHR), helps busy clinicians to quickly understand the patient's complaints, document their symptoms and GI history, and leaves more time for conversation with the patient. Beyond focusing their interaction, My GI Health also supports both the clinician and patient with an individualized "educational prescription" which guides the patient through a library of multi-media educational materials on GI symptoms, conditions, and treatments also contained within the website. The prescription is initially created by the website based o
Conditions Studied
Interventions
- OTHER AEGIS (Automated Evaluation of Gastrointestinal Symptoms)
Study Locations (3)
California
- Cedars-Sinai Medical Center - Los Angeles
- West Los Angeles VA Medical Center - Los Angeles
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02436057
The ClinicalTrials.gov registry entry for NCT02436057 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 201-participant average among 54 other Constipation trials with a reported enrollment target (27% higher). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Constipation appearing as the primary indexed condition, and to 1 intervention - of which AEGIS (Automated Evaluation of Gastrointestinal Symptoms) is the first listed.
NCT02436057 reports 3 study locations spanning 2 distinct geographic areas - top geographies include California, Michigan.
Frequently Asked Questions
What is clinical trial NCT02436057 about?
NCT02436057 is a clinical study titled "Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform". Through a four-year grant awarded to the University of California at Los Angeles in 2009, Dr. Brennan Spiegel served as a principal investigator (PI) for a project to develop and initially validate a bank of items to assess gastrointestinal (GI) symptoms for the National Institutes of Health's (NIH'...
What is the current status of trial NCT02436057?
This trial is currently completed. It is a NA study. The enrollment target is 255 participants. The study started on 2014-07. Estimated completion is 2015-12.
What conditions does trial NCT02436057 study?
This clinical trial studies the following conditions: Constipation, Gastroesophageal Reflux, Diarrhea, Fecal Incontinence, Abdominal Pain.
What interventions are being tested in trial NCT02436057?
The interventions under investigation include: AEGIS (Automated Evaluation of Gastrointestinal Symptoms) (OTHER).
Who is sponsoring clinical trial NCT02436057?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02436057 being conducted?
This trial has 3 study locations across California, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Constipation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimization of Postoperative Bowel Habits
RECRUITING · NA
-
Management of Dyssynergic Defecation
RECRUITING · NA
-
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
RECRUITING · NA
-
Fecobionics in Biofeedback Therapy in Dyssynergia Patients
RECRUITING · NA
-
Understanding Mechanisms of Normal and Disordered Defecation
RECRUITING · NA
-
Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.